Document ID: chunk:federal_register_of_legislation:F2022L01382:reg:6
Version: federal_register_of_legislation:F2022L01382
Segment Type: reg
Provision Reference: reg 6
Character Range: 1497–3007

6               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about portal vein thrombosis and death from portal vein thrombosis.
Meaning of portal vein thrombosis
(2)          For the purposes of this Statement of Principles, portal vein thrombosis:
(a)          means formation of a blood clot within the portal vein; and
(b)          includes pylephlebitis and suppurative pylephlebitis; and
(c)          excludes:
                (i)            intentional occlusion by intravascular embolisation of the affected portal vein, or a blood vessel or arteriovenous fistula that is contiguous with the affected portal vein; and
                (ii)         portal vein thrombosis occurring in the context of vaccine-induced thrombotic thrombocytopaenia.
                Note 1: Typically, patients with portal vein thrombosis are asymptomatic, but clinical manifestations can include abdominal pain and fever. Gastrointestinal bleeding is common in patients with chronic portal vein thrombosis.
                Note 2: intravascular embolisation and pylephlebitis are defined in the Schedule 1 – Dictionary.

Death from portal vein thrombosis
(3)          For the purposes of this Statement of Principles, portal vein thrombosis, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's portal vein thrombosis.
Note: terminal event is defined in the Schedule 1 – Dictionary.